Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Feature Articles
7/24/2024
Breaking Barriers and Accelerating Growth: Clinical Trials, Drug Appro...
7/24/2024
Why (And How) to HIDE Your IP from an Increasingly Rapacious China (Mo...
7/19/2024
Experts Predict Novo Victory in Grueling Chinese Patent Case (MedWatcj...
7/16/2024
China's Health Supplements Market: Trends and Opportunities for Busine...
7/16/2024
Who Will Acquire Legend Bio for 13B to 15B USD? Could It Be J&J? (Drug...
7/15/2024
China's Once-booming Online Healthcare Sector Sees Its Vital Signs Sin...
7/15/2024
Will US Clinical Study Diversity Guidance Cloud Chinese Firms' Prospec...
7/15/2024
China Biopharma Tracker – H1/2024 (PharmaNJ)
7/15/2024
China's Fast-following Approach Positions It at the Forefront of the F...
7/12/2024
Prominence of Asia in Global Pharma Clinical Trials Rising Substantial...
7/11/2024
Political Change Around China Means Change for Pharma (The Medicine Ma...
7/11/2024
Biopharma Partnership Interest with China Remains High: LEK Survey
7/10/2024
House Speaker Mike Johnson Pledges Vote for BIOSECURE as China-targeti...
7/9/2024
China's Pharmaceutical Industry Bets Big on Small Nucleic Acid Drugs i...
7/9/2024
China's Supreme People's Court Clarifies Priority Examination Standard...
7/2/2024
What is the Current Landscape of Obesity Drug Development in China? (L...
6/27/2024
Industry Braces for Biosecure Act Impact (C&EN)
6/26/2024
On Efficiency of China's Drug-Related Patent Term Compensation System ...
6/25/2024
Leveraging Injunctive Relief in Pharmaceutical Patent Disputes in Chin...
6/20/2024
Cheaper Versions of Blockbuster Obesity Drugs Are Being Created in Ind...
6/19/2024
Big Changes to China's BMI System Expected at 3rd Plenum (Pekingnology...
6/18/2024
China Biopharma Tracker – May 2024 (PharmaDJ)
6/14/2024
In Depth: How China's Pricing Regime Penalizes Innovative Drugmakers (...
6/4/2024
China Biotech Podcast: Going Global Trends, Rare Disease Drug Developm...
6/3/2024
Western Companies Drive Chinese Biotech Licensing Deal Blitz (FT)
5/31/2024
Building Resilient Supply Chains in the Face of Tightening Chinese Ant...
5/31/2024
Manufacturing Inspections Down in China amid Arrest Fears and No Acces...
5/30/2024
U.S. Rethinks Timing of Biotech Crackdown, Easing Pressure on WuXi Fam...
5/29/2024
Caixin Explains: How China Is Overhauling Regulations on Genetic Resou...
5/23/2024
Hong Kong Emerges As Global Health Innovation Hub Under China New Plan...
Page:
6
/
7
Total number of articles:
195
:
[First]
[<<]
[3]
[4]
[5]
[6]
[7]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit